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Abstract
Purpose Management of patients with persisting pain after spine surgery (PPSS) shows significant variability, and there 
is limited evidence from clinical studies to support treatment choice in daily practice. This study aimed to develop patient-
specific recommendations on the management of PPSS.
Methods Using the RAND/UCLA appropriateness method (RUAM), an international panel of 6 neurosurgeons, 6 pain 
specialists, and 6 orthopaedic surgeons assessed the appropriateness of 4 treatment options (conservative, minimally inva-
sive, neurostimulation, and re-operation) for 210 clinical scenarios. These scenarios were unique combinations of patient 
characteristics considered relevant to treatment choice. Appropriateness had to be expressed on a 9-point scale (1 = extremely 
inappropriate, 9 = extremely appropriate). A treatment was considered appropriate if the median score was ≥ 7 in the absence 
of disagreement (≥ 1/3 of ratings in each of the opposite sections 1–3 and 7–9).
Results Appropriateness outcomes showed clear and specific patterns. In 48% of the scenarios, exclusively one of the 4 
treatments was appropriate. Conservative treatment was usually considered appropriate for patients without clear anatomic 
abnormalities and for those with new pain differing from the original symptoms. Neurostimulation was considered appro-
priate in the case of (predominant) neuropathic leg pain in the absence of conditions that may require surgical intervention. 
Re-operation could be considered for patients with recurrent disc, spinal/foraminal stenosis, or spinal instability.
Conclusions Using the RUAM, an international multidisciplinary panel established criteria for appropriate treatment choice 
in patients with PPSS. These may be helpful to educate physicians and to improve consistency and quality of care.
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s0058 6-018-5711-0) contains 
supplementary material, which is available to authorized users.
Extended author information available on the last page of the article
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Graphical abstract These slides can be retrieved under Electronic Supplementary Material. 
Key points 
 
Keywords:  Spinal surgery, Failed Back Surgery Syndrome, 
Neurostimulation, RAND/UCLA Appropriateness Method, Consensus, 
Best practices 
 
1. The management of persistent pain after spine surgery shows large 
variations. Evidence from clinical studies to support treatment 
choice is limited. 
2. A multidisciplinary European expert panel used the RAND/UCLA 
Appropriateness Method to produce patient-specific 
recommendations. 
3. The panel results may be used for educational activities aiming at 
supporting a multidisciplinary clinical decision setting. 
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Take Home Messages
1. Conservative treatment is most appropriate for patients without 
clear anatomic abnormalities and for those with new pain differing 
from the original symptoms.
2. Neurostimulation is an appropriate option in the case of 
(predominant) neuropathic leg pain in the absence of conditions 
that require surgical intervention.
3. Re-operation could be considered for patients with recurrent disc, 
spinal/foraminal stenosis or spinal instability.
4. Appropriateness of treatment is dependent on specific 
combinations of relevant patient characteristics.
Tronnier VM, et al. (2018) The appropriate management of persisting pain after spine 
surgery – A European panel study with recommendations based on the RAND/UCLA 
method. Eur Spine J;
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Introduction
Spinal decompression (including removal of herniated discs) 
and spinal fusion are frequently performed surgical proce-
dures in patients with back and/or leg pain due to degen-
erative lumbar spine disease. In the UK, the frequency of 
this type of surgery increased from 25 to 49 per 100,000 in 
the population over the period 1999–2013 [1]. In the USA, 
the surgery rate is considerably higher (135 per 100,000 in 
2013), but does not show a further increase [2].
Unfortunately, there is a considerable proportion of 
patients who experience recurrent or remaining pain follow-
ing initial spine surgery, ranging from 3 to 34% at follow-up 
between 6 and 24 months after surgery, and 5 to 36% upon 
long-term evaluation (> 2 years) [3, 4]. A recent population-
based cohort study in England reported that over the period 
2007–2012 on average 20.8% of lumbar surgery patients 
experienced persistent post-operative pain [5]. Unsatis-
factory results after spinal surgery are often referred to as 
“failed back surgery syndrome” (FBSS), but this term has 
been criticised because it unilaterally puts the blame on the 
operation as the cause of the problem, while the aetiology is 
much more complex and often multifactorial [6–9].
In a systematic review of 40 studies on lumbar discec-
tomy, the predictive value of 95 preoperative factors for 
post-operative clinical outcomes was explored [10]. The 
study revealed 17 factors associated with a positive surgical 
outcome including more severe leg pain and better men-
tal health status. A negative association with surgical out-
come was seen for some anatomic characteristics, but also 
for patient-related social factors such as worker’s compen-
sation. For 61% of the factors, including age and sex, the 
results were not significant or conflicting [10]. A second-
ary analysis of the data from a randomised controlled trial 
(RCT) and subsequent cohort study on lumbar discectomy 
showed that the 1- and 3-year risk of recurrent pain was sub-
stantially lower in patients with complete initial resolution 
of leg pain [11]. Other predictive factors that are currently 
studied include the origin and nature of the pain (nociceptive 
versus neuropathic pain) [12–14], sagittal balance [15, 16], 
and anatomic characteristics such as the presence of root 
compression [17] and the type of stenosis [18].
For patients with persisting or recurrent pain after spinal 
surgery (PPSS), a variety of treatments is used, including 
conservative treatments (pain medication, physical therapy, 
psychological rehabilitation, and graded activity), neuro-
stimulation, minimally invasive treatments (a.o selective 
nerve root blocks, facet and sacroiliac joint infiltration/den-
ervation, epidural injections, often primarily used as a diag-
nostic procedure), and re-operation. Clinical studies on most 
of these treatment modalities are scarce and often of limited 
quality. Most (randomised controlled) clinical studies have 
been performed for spinal cord stimulation (SCS) [19] and 
some minimally invasive treatments [20]. A recent system-
atic review suggested epidural adhesiolysis to be effective 
in the short term [21]. SCS was shown to be efficacious in 
studies with a follow-up of 2–3 years, and proved to be more 
efficacious than conventional medical management and re-
operation in distinct patient groups [19, 21]. For other treat-
ments, including re-operation, the authors considered the 
evidence from available studies to be poor or inconclusive 
[21]. Similar outcomes were found in a recent comprehen-
sive review in this journal, though the researchers suggested 
that there is also sufficient evidence to recommend active 
exercise as a treatment option [22].
The availability of many treatment modalities and lim-
ited evidence from clinical studies has induced large prac-
tice variations. This variability is further enlarged by the 
heterogeneity of the patient population and the (potential) 
involvement of different specialties in the management of 
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PPSS (general practitioners, pain specialists, neurosurgeons, 
orthopaedic surgeons, neurologists, and rehabilitation physi-
cians). A number of guidelines and algorithms focusing on, 
or including recommendations on the management of PPSS 
have been published [6, 23–27]. However, these are often 
either not very specific, or too much focused on single treat-
ments or specialties. This study sought to establish patient-
specific recommendations for the management of PPSS from 
a multidisciplinary perspective, combining evidence from 
clinical studies and practice experience of an international 
expert panel.
Materials and methods
The appropriateness of treatments for persisting pain after 
spine surgery (PPSS) was assessed using the RAND/UCLA 
Appropriateness Method  (RUAM) [28]. This modified 
Delphi method has been used to establish appropriateness 
criteria for surgical, medical, and diagnostic procedures in 
various fields of medicine [29]. It aims at integrating scien-
tific knowledge and clinical insights of experts to produce 
detailed statements “regarding the appropriateness of per-
forming a procedure at the level of patient-specific symp-
toms, medical history, and test results” [29]. The method 
is particularly helpful when evidence from clinical studies 
is insufficient to cover the heterogeneity of patients seen in 
daily clinical practice [29]. The RUAM consists of a struc-
tured and iterative process of individual (independent and 
anonymous) rating rounds and plenary discussion meetings. 
Results of various methodological and outcome studies sup-
port the reliability, internal consistency, and clinical validity 
of the RUAM [30–35].
Panel composition
Panel composition was based on an equal representation of 
the 3 specialties that are most involved in the treatment of 
patients with PPSS: neurosurgery, pain medicine, and ortho-
paedic surgery. Individual panellists were selected on the 
basis of their scientific and clinical expertise, as well as their 
involvement in guideline development in the field of PPSS. 
Furthermore, a reasonable geographic spread over Europe 
was pursued. The panel included 6 neurosurgeons, 6 anaes-
thetists/pain specialists, and 6 orthopaedic surgeons from 
9 European countries (Belgium, France, Germany, Italy, 
Spain, The Netherlands, Sweden, Switzerland, and the UK).
Literature overview
A literature study was conducted to support shaping the 
starting points of the study, and to ensure that participants 
had access to the same body of evidence during the panel 
process. To avoid interpretation bias, materials were pro-
vided as an overview, rather than as a review.
Panel process
The flow of the panel study is depicted in Fig. 1. During the 
first panel meeting (Amsterdam, October 2016), the panel 
discussed the patient population to be considered, treatments 
to be included, and factors that may be relevant to treatment 
choice.
The panel agreed to restrict the study to patients with:
(a) Persisting, recurrent, or new pain after previous spinal 
surgery for degenerative disease
(b) Symptom duration of ≥ 6 months after disc or decom-
pression surgery, and ≥ 12 months after spinal fusion
(c) At least moderate symptoms (cf. VAS ≥ 4) with at least 
moderate impact on daily functioning (based on, e.g. 
the Oswestry Disability Index or Roland Morris Dis-
ability Questionnaire) and quality of life (based on, e.g. 
the SF36)
(d) Absence of “red flags” (e.g. infectious or malignant 
lesions, bowel or bladder paralysis)
(e) Age ≥ 18 years
(f) Absence of absolute contraindications for active treat-
ment (e.g. unfit for surgery, pregnancy, spine infection, 
and coagulation disorder)
(g) Absence of severe psychological disease and/or distress
Study preparaon
First panel meeng
First rang round
Second panel meeng
Second rang round
Teleconference
• Explanaon of method
• Defining the starng points
Individual rangs of 4 treatment 
opons for 324 clinical scenarios
• Feedback and discussion on 1st round results
• Revision of rang structure
Individual rangs of  4 adapted treatment 
opons for 210 revised  clinical scenarios
• Literature review
• Selecon of panel members
• Feedback, discussion, and approval of  2nd
round results
Fig. 1  Flow diagram of the panel study
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The panel acknowledged the importance of psychological 
aspects of chronic pain, but wished to focus on somatosen-
sory aspects. For that reason, the psychological dimension of 
PPSS and its impact on treatment choice was not considered 
in this study.
Selected treatment options for the first round were con-
servative treatment, spinal cord stimulation, re-operation, and 
“specialised diagnostic evaluation” (including facet denerva-
tion, root blocks, and spinal endoscopy). The panel identi-
fied a number of variables that may be relevant to treatment 
choice: previous spinal surgery (decompression/fusion), onset 
of pain (remaining/recurrent), location of pain (leg/back/
mixed), type of pain (neuropathic/nociceptive/mixed), con-
cordance of signs and symptoms with anatomic abnormalities 
(yes/no/uncertain), and age (< 50, 50–70, > 70 years).
The panel extensively discussed the definitions of neuro-
pathic and nociceptive pain to be used. It was agreed that the 
taxonomy of the International Association for the Study of 
Pain (IASP) is a good concept [36], but that its application in 
PPSS is sometimes problematic, and may confuse the appro-
priateness ratings. For that reason, it was decided to use the 
term neuropathic (like) pain in the ratings, thereby includ-
ing a broader group of patients with neuropathic signs and 
symptoms than would fit within the IASP definition. This 
approximates more the reality of presentation of complaints 
of patients with PPSS. For reasons of brevity, the term neu-
ropathic pain will be used throughout this manuscript.
By permutation of the clinical variables, a set of 324 
mutually exclusive scenarios (unique patient profiles) was 
constructed. Using an electronic rating program, panellists 
individually assessed the appropriateness of the 4 treatment 
options for all 324 scenarios using a 9-point scale (refer-
ence values: 1 = inappropriate, 5 = uncertain, 9 = appropri-
ate). According to the RUAM definition, a treatment was 
considered appropriate if the expected benefits outweigh 
the expected negative consequences by a sufficient margin 
[29]. Panellists were instructed to take the clinical perspec-
tive as a starting point, and to disregard cost and reimburse-
ment of treatments. The rating results were discussed dur-
ing the second panel meeting (Paris, April 2017). Panellists 
received feedback on their own ratings in comparison with 
the anonymous results of their colleagues. The panel discus-
sion led to a number of adaptations to the clinical variables, 
treatment options, and definitions. The final set included 1 
variable with 2 categories, 3 variables with  3 categories, 
and 1 variable with 5 categories (Table 1), summing up to 
 (21 * 33 * 51 =) 270 scenarios. After exclusion of 60 scenarios 
that the panel considered to be unrealistic or falling beyond 
the scope of this study (for example nociceptive leg pain), 
210 scenarios remained for which the appropriateness of 
treatments was assessed during the second round. Final 
recommendations were established and approved during 
a web conference (October 2017). An overview of clinical 
Table 1  Overview of clinical 
variables and treatment options 
used for the construction of 
patient scenarios in the second 
rating round
a Nociceptive leg pain was excluded from the ratings, as this type of pain was believed to be usually unre-
lated to previous spinal surgery
Clinical variables
 Previous spinal surgery (a) Non-instrumented
(b) Instrumented/fusion
 Onset of pain (a) Remaining
(b) Recurrent
(c) New (other than initial pain)
 Location of pain (a) Predominantly  lega
(b) Predominantly back
(c) Mixed
 Type of pain (a) Predominantly neuropathic (cf. DN4 ≥ 4)
(b) Predominantly  nociceptivea
(c) Mixed
 Anatomic abnormality (a) Recurrent disc
(b) Pronounced scar tissue or iatrogenic lesion
(c) Spinal or foraminal stenosis
(d) Spinal instability
(e) None or not concordant with symptoms
 Treatment options (a) Conservative treatment
(includes physiotherapy, pharmacological therapy, rehabilitation 
therapy, intensive pain program)
(b) Minimally invasive treatment
(may include interventional techniques such as selective nerve root 
blocks, facet and sacroiliac joint infiltration/denervation, pulsed 
radiofrequency and epidural injection)
(c) Neurostimulation (all types)
(d) Re-operation (all types)
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variables and treatment options used in the second round is 
provided in Table 1.
Classification of appropriateness and statistical 
analysis
Similar to most RUAM studies, appropriateness of treat-
ments was classified using the median panel score and extent 
of agreement between panellists [29]. The outcome was 
considered appropriate if the median score was between 7 
and 9, and inappropriate if the median was between 1 and 
3, without disagreement between panellists. Disagreement 
was defined as the situation in which at least one-third of the 
panellists scored in each of the sections 1–3 and 7–9 [29]. 
All other outcomes were deemed “uncertain”. Frequency 
tables and cross-tabulations were used to describe the appro-
priateness outcomes by treatment choice, clinical variables, 
and specialty. Multivariate logistic regression was used to 
analyse underlying patterns and to determine the internal 
consistency of the ratings. All statistical analyses were per-
formed using IBM SPSS for Windows version 25.
Results
Agreement and appropriateness
For all indications together, disagreement after the second 
round was 8%. Dispersion of opinions was highest for mini-
mally invasive treatment and re-operation in patients with 
predominant back pain (disagreement 68 and 88%, respec-
tively). Appropriateness outcomes for the theoretical patient 
population are shown in Fig. 2.
Conservative treatment was considered appropriate 
for around two-thirds of cases. The choice for minimally 
invasive treatments showed the highest proportion of uncer-
tainty (84%). Inappropriate indications were seen for neu-
rostimulation (15%) and re-operation (37%). The “rating 
behaviour” of individual panel members showed large vari-
ations: the proportion of ratings in the sections 1–3, 4–6, 
and 7–9 ranged from 0 to 46%, 3 to 65%, and 15 to 65%, 
respectively. However, differences in appropriateness out-
comes across specialties were modest (Fig. 3). The differ-
ence between the mean median scores was at most 1.1 points 
on the 9-point scale.
The appropriateness of treatments by clinical variables 
is shown in Table 2.
Evidence for anatomic abnormality appeared to be the 
most discriminative variable. Conservative treatment was 
considered appropriate for most patients with pronounced 
scar tissue or iatrogenic lesion and for those with no or 
inconclusive evidence for an anatomic abnormality. The 
same factors were obviously considered as a contraindi-
cation for re-operation. Spinal instability proved to be an 
important factor in favour of re-operation, and against mini-
mally invasive treatment and neurostimulation. The presence 
of predominant leg pain was the strongest single factor in 
favour of neurostimulation, while the presence of predomi-
nant nociceptive (back) pain was the most important factor 
against this treatment option. The impact of the type of pre-
vious surgery was only significant for minimally invasive 
treatment: this treatment option was not considered appro-
priate for most patients with previous instrumented surgery 
and fusion. Onset of pain was most relevant for the choice of 
conservative treatment. The appropriateness of this option 
0% 25% 50% 75% 100%
Re-operaon
Neurosmulaon
Minimally invasive treatment
Conservave treatment
Inappropriate Uncertain Appropriate
Fig. 2  Appropriateness of treatment; second round results. Percent-
age of the 210 clinical scenarios for which the panel outcome was 
appropriate, inappropriate, or uncertain
1
2
3
4
5
6
7
8
9
CON MIN NEU ROP
Neurosurgeons
Anaesthests
Orthopaedic surgeons
Mean median scores by specialty
Fig. 3  Appropriateness of treatments by specialty; CON = conserva-
tive treatment, MIN = minimally invasive treatment, NEU = neuro-
stimulation, ROP = re-operation
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was substantially higher in patients with new pain, i.e. dif-
ferent from the type of pain for which the initial surgery 
took place.
Logistic regression analysis, with the outcome appropri-
ate (yes/no) as the dependent variable and including all clini-
cal variables as explanatory factors, confirmed the appropri-
ateness patterns of the 4 treatment options, with predictive 
values for the statistical models varying between 83 and 94% 
at a cut-off value of 0.5. Appropriateness outcomes were 
highly specific. In 48% of the scenarios, only one of the 
treatment options was appropriate, and in another 39%, at 
most two options were appropriate. Principal appropriate-
ness patterns are shown in Fig. 4. Detailed tables are pro-
vided in “Appendix 1”.
Discussion
Due to the heterogeneity of the patient population and the 
variety of available treatment modalities, the management of 
PPSS requires an individualised approach, taking into consid-
eration both physical and psychological aspects. This study 
focused on the somatosensory dimension of treatment choice. 
The RUAM proved to be helpful in identifying key variables 
from the perspective of daily clinical practice. Moreover, 
opinions on the appropriateness of treatments for 210 distinct 
patient profiles were remarkably in line across the specialties 
involved (Fig. 3). This is deviant from other RUAM studies 
that have shown a significant impact of panellist discipline on 
the ratings [30]. Furthermore, the appropriateness outcomes 
tended to be highly specific as in 48 and 87% of scenarios 
exclusively one or maximally two treatments were considered 
appropriate. The results of regression analysis support the 
internal consistency of the panel data.
Comparison with guidelines and algorithms
Evidence for anatomic abnormality proved to be the most 
discriminative variable in relation to the appropriateness 
of treatments. The absence of an anatomic abnormality or 
discordance with symptoms clearly and logically rules out 
surgical intervention, including minimally invasive proce-
dures. Similar results were seen for patients with pronounced 
scar tissue or an iatrogenic lesion, with the difference that 
minimally invasive treatments may sometimes be an option 
here (Fig. 3). Available guidelines and algorithms do not 
explicitly give recommendations on scar tissue and iatro-
genic lesion [6, 23–27]. However, there is general agree-
ment in the surgical community that an already partially or 
completely damaged nerve or nerve root causing chronic 
neuropathic pain cannot be restored with any kind of sur-
gery, and symptomatic pain therapy in a multidisciplinary 
setting is required [37, 38]. For patients with spinal instabil-
ity, re-operation is the most appropriate option. Conservative 
treatment in these patients may also be appropriate, (particu-
larly) if the pain is different from the original pain for which 
Table 2  Appropriateness of treatments by clinical variables
Percentage of scenarios by subgroup for which the outcome was appropriate. Multiple treatment options can be appropriate for the same scenario
Differences in appropriateness (appropriate versus inappropriate/uncertain) were analysed using the Pearson’s Chi square test for categorical 
data. Bold figures indicate statistically significant differences with p < 0.001
CON =  conservative treatment, MIN  = minimally invasive treatment, NEU =  neurostimulation, ROP =   re-operation
Variable Category (# scenarios) CON (%) MIN (%) NEU (%) ROP (%)
Previous spinal surgery Non-instrumented (105) 64 31 28 46
Instrumented/fusion (105) 62 2 35 34
Onset of pain Remaining (70) 44 11 30 41
Recurrent (70) 61 14 33 43
New (70) 83 23 31 36
Location of pain Predominantly leg (30) 50 17 73 50
Predominantly back (90) 75 16 9 24
Mixed leg/back (90) 56 17 40 52
Type of pain Predominantly neuropathic (90) 58 11 56 36
Predominantly nociceptive (60) 65 20 0 45
Mixed (60) 68 20 27 42
Evidence for anatomic abnormality Recurrent disc (42) 45 19 31 45
Pronounced scar tissue or iatrogenic lesion (42) 95 29 60 0
Spinal/foraminal stenosis (42) 48 31 26 60
Spinal instability (42) 29 0 2 95
None/not concordant with symptoms (42) 98 2 38 0
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previous spinal surgery took place (see “Appendix 1”). Re-
operation was considered an appropriate option for most 
patients with a recurrent disc herniation or spinal/foraminal 
stenosis, and having predominant leg or mixed leg/back pain 
(Table 2, “Appendix 1”). Most currently available guidelines 
and algorithms do either not mention, or are not very specific 
on the indications for re-operation [6, 23–25]. The algorithm 
by Van Buyten and Linderoth is close to our findings in 
this respect, as it considers re-operation indicated in patients 
with (recurrent) disc herniation and leg pain prevailing over 
back pain [27]. The algorithm suggested by Rigoard and 
Assaker is also largely in line with our recommendations, 
albeit that their specification of the related type of symptoms 
is different (“mixed back pain” or “exclusive/predominant 
axial back pain”) [26]. According to the panel, neurostimula-
tion is most appropriate in patients with predominant neuro-
pathic leg or mixed leg/back pain, and without clear surgical 
indications such as spinal instability. This is in accordance 
with the inclusion criteria of some, but not all RCTs that 
have studied spinal cord stimulation for “failed back surgery 
syndrome” [39, 40], albeit that different terms have been 
used such as “radicular pain” or “neuropathic pain of radicu-
lar origin” [39, 40]. The recommendations are also largely in 
line with the guidelines and algorithms in which neurostimu-
lation was mentioned [6, 23–27]. Neurostimulation was also 
considered appropriate in the case of scar tissue or a iatro-
genic lesion (Table 2), mostly in patients with a neuropathic 
leg pain component, but also for patients with exclusively 
neuropathic or mixed back pain (Fig. 4). The efficacy of 
SCS for PPSS patients with predominant low back pain is 
currently under study [41]. Minimally invasive treatments 
showed some specific indications for patients with (mostly) 
back or mixed leg/back pain after non-instrumented previ-
ous spinal surgery (Fig. 4, “Appendix 1”). Some guidelines 
and algorithms advise selective root blocks, radiofrequency, 
and epidural injections as a first (diagnostic) step in specific 
situations (e.g. suspected facet joint syndrome) [6, 26]. The 
overall panel recommendations are summarised in Table 3.
Strengths and limitations
Although the use of detailed clinical scenarios and the 
involvement of different specialties may be considered as 
strong points of this study, it still is a first step towards an 
individualised and multidisciplinary approach of managing 
PPSS.
The panel consisted of 3 different specialities, but there 
are many other disciplines that are involved in the manage-
ment of persisting pain after spine surgery, and that all could 
have had a significant contribution to this project. However, 
the number of participants had to be limited to allow every-
one to be involved in the group discussion. In addition, to 
be able to detect potential differences between specialities, 
a minimum number per specialty was needed. For these rea-
sons, the panel was restricted to the primary decision-makers 
from both the spine and pain perspectives.
Although a variety of patient scenarios was used, the 
recommendations relate to a theoretical population and 
the applicability of the clinical factors and the distribution 
of scenarios need to be determined in daily practice. For 
C M N R C M N R C M N R C M N R C M N R
NP leg A I A I A U A I U I I A U U A M M M M A
NP back A I U I A U A I M I I A M U U N M U U U
NP leg+back A I A I A U A I U I I A M U A M M M A M
NO back A I I I A M N I M I I A M U I U M U I M
NO leg+back A I U I A M U I U I I A U M U A M M U A
NP/NO back A I U I A M M I M I I A M U U U A M U U
NP/NO leg+back A I M I A U A I U I I A M M M A M M M A
None / not 
concordant
with symptoms
Scar ssue 
or iatrogenic
lesion
Spinal
instability
Recurrent
disc
Spinal or
foraminal
stenosis
Evidence for anatomic abnormality
C = Conservave treatment
M = Minimally invasive treatment
N = Neurosmulaon
R = Re-operaon
Mostly appropriate
Mostly inappropriate
Mostly uncertain 
Mixed appropriate and uncertain
Mixed inappropriate and uncertain
A
I
U
M
N
NP = neuropathic
NO = nocicepve
Locaon and type 
of pain
Fig. 4  Main appropriateness patterns. Summarised panel outcomes by key variables
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reasons of practicability, a set of relatively simple variables 
without extensive definition was chosen. As was also noticed 
during the panel discussions, some of these may need fur-
ther refinement. This is particularly true for the concept of 
neuropathic (versus nociceptive or mechanical) pain for 
which there is currently much debate on its precise nature 
[14, 42–45] and role in the diagnostic evaluation and treat-
ment choice for patients with PPSS [12–14, 46, 47]. Fur-
ther research may also consider the inclusion of additional 
somatic variables, potentially relevant to treatment choice, 
such as sagittal balance [15, 16].
The focus of this study was on somatosensory aspects 
which is surely an important limitation. Psychological and 
social aspects are very important in the management of 
PPSS, but including this dimension would have substantially 
increased the complexity and extensiveness of the study. 
This study should therefore be considered as a foundation 
on which further refinements can be made.
Conclusions
The lack of coherence in the management of PPSS and large 
practice variations urge consensus development from a mul-
tidisciplinary perspective. Using the RUAM, an international 
panel of pain and spine specialists established a set of appro-
priateness criteria for conservative, minimally invasive, and 
surgical interventions. These could be a starting point to 
improve consistency of care, to further design more specific 
studies, and to reduce undesirable practice variations. The 
study outcomes, both the summarised recommendations and 
look-up tables, may be used for reflection on individual clini-
cal decisions, and also for discussion in educational settings. 
However, validity and applicability of the panel recommen-
dations in daily clinical practice need further study.
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Table 3  Summarised panel recommendations
Usually appropriate in patients with: Usually not appropriate in patients with:
Conservative treatment No evidence of anatomic abnormalities or not concordant with symp-
toms
Scar tissue or iatrogenic lesion
Minimally invasive treatment Patients with recurrent disc, spinal/foraminal stenosis, scar tissue or 
iatrogenic lesion after non-instrumented previous surgery, having 
back or mixed leg/back pain
Spinal instability
No evidence of anatomic abnormalities 
or not concordant with symptoms
Neurostimulation Neuropathic leg/back pain without clear indications for re-operation
Neuropathic leg/back pain due to pronounced scar tissue or iatrogenic 
lesion
Exclusively nociceptive pain
Spinal instability
Re-operation Spinal instability
Recurrent disc, spinal or foraminal stenosis, in the presence of symp-
toms concordant with imaging
Scar tissue or iatrogenic lesion
No evidence of anatomic abnormalities 
or not concordant with symptoms
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Appendix 1: Appropriateness by clinical 
variables
See Tables 4, 5, 6, 7 and 8.    
Table 4  Appropriateness of treatments for patients with anatomic evidence of recurrent disc
Treatment
Previous
Surgery
Onset
of pain
Location
of pain
Type
of pain CON MIN NEU ROP
Non-instrumented Remaining Leg Neuropathic U U A A
Non-instrumented Remaining Back Neuropathic U U U U
Non-instrumented Remaining Back Mixed U U U U
Non-instrumented Remaining Back Nociceptive U U I U
Non-instrumented Remaining Mixed Neuropathic U U A U
Non-instrumented Remaining Mixed Mixed U A A A
Non-instrumented Remaining Mixed Nociceptive U A I A
Non-instrumented Recurrent Leg Neuropathic U A A A
Non-instrumented Recurrent Back Neuropathic A U U U
Non-instrumented Recurrent Back Mixed A U U U
Non-instrumented Recurrent Back Nociceptive A U I U
Non-instrumented Recurrent Mixed Neuropathic A U A A
Non-instrumented Recurrent Mixed Mixed A A U A
Non-instrumented Recurrent Mixed Nociceptive A A U A
Non-instrumented New Leg Neuropathic U U U A
Non-instrumented New Back Neuropathic U A U U
Non-instrumented New Back Mixed A A U A
Non-instrumented New Back Nociceptive A A I U
Non-instrumented New Mixed Neuropathic U U A A
Non-instrumented New Mixed Mixed A U U A
Non-instrumented New Mixed Nociceptive U U U A
Instrumented/fusion Remaining Leg Neuropathic U U A U
Instrumented/fusion Remaining Back Neuropathic A U U U
Instrumented/fusion Remaining Back Mixed A U U U
Instrumented/fusion Remaining Back Nociceptive A U I U
Instrumented/fusion Remaining Mixed Neuropathic U U A A
Instrumented/fusion Remaining Mixed Mixed U U U A
Instrumented/fusion Remaining Mixed Nociceptive U U U A
Instrumented/fusion Recurrent Leg Neuropathic U U A A
Instrumented/fusion Recurrent Back Neuropathic U U U U
Instrumented/fusion Recurrent Back Mixed U U U U
Instrumented/fusion Recurrent Back Nociceptive U U I U
Instrumented/fusion Recurrent Mixed Neuropathic A U A U
Instrumented/fusion Recurrent Mixed Mixed U U U U
Instrumented/fusion Recurrent Mixed Nociceptive U U U A
Instrumented/fusion New Leg Neuropathic A U A U
Instrumented/fusion New Back Neuropathic A U U I
Instrumented/fusion New Back Mixed A U U U
Instrumented/fusion New Back Nociceptive A U U U
Instrumented/fusion New Mixed Neuropathic A U A U
Instrumented/fusion New Mixed Mixed A U A A
Instrumented/fusion New Mixed Nociceptive U U U A
CON = conservative treatment
MIN = minimally invasive treatment A Appropriate
NEU = neurostimulation U Uncertain
ROP = re-operation I Inappropriate
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Table 5  Appropriateness of treatments for patients with anatomic evidence of pronounced scar tissue or iatrogenic lesion
Treatment
Previous
Surgery
Onset
of pain
Location
of pain
Type
of pain CON MIN NEU ROP
Non-instrumented Remaining Leg Neuropathic A U A I
Non-instrumented Remaining Back Neuropathic A U U I
Non-instrumented Remaining Back Mixed A A U I
Non-instrumented Remaining Back Nociceptive A A I I
Non-instrumented Remaining Mixed Neuropathic A U A I
Non-instrumented Remaining Mixed Mixed A U A I
Non-instrumented Remaining Mixed Nociceptive A A U I
Non-instrumented Recurrent Leg Neuropathic A U A U
Non-instrumented Recurrent Back Neuropathic A A A I
Non-instrumented Recurrent Back Mixed A A A U
Non-instrumented Recurrent Back Nociceptive A A U I
Non-instrumented Recurrent Mixed Neuropathic A U A I
Non-instrumented Recurrent Mixed Mixed A U A I
Non-instrumented Recurrent Mixed Nociceptive A U U U
Non-instrumented New Leg Neuropathic A A A I
Non-instrumented New Back Neuropathic A U A I
Non-instrumented New Back Mixed A A U U
Non-instrumented New Back Nociceptive A A I U
Non-instrumented New Mixed Neuropathic A U A I
Non-instrumented New Mixed Mixed A A A I
Non-instrumented New Mixed Nociceptive A A U U
Instrumented/fusion Remaining Leg Neuropathic A U A I
Instrumented/fusion Remaining Back Neuropathic A U A I
Instrumented/fusion Remaining Back Mixed A U U I
Instrumented/fusion Remaining Back Nociceptive A U U I
Instrumented/fusion Remaining Mixed Neuropathic U U A I
Instrumented/fusion Remaining Mixed Mixed U U A U
Instrumented/fusion Remaining Mixed Nociceptive A U U U
Instrumented/fusion Recurrent Leg Neuropathic A U A I
Instrumented/fusion Recurrent Back Neuropathic A U A I
Instrumented/fusion Recurrent Back Mixed A U U I
Instrumented/fusion Recurrent Back Nociceptive A U U I
Instrumented/fusion Recurrent Mixed Neuropathic A U A I
Instrumented/fusion Recurrent Mixed Mixed A U A I
Instrumented/fusion Recurrent Mixed Nociceptive A U U I
Instrumented/fusion New Leg Neuropathic A U A I
Instrumented/fusion New Back Neuropathic A U A I
Instrumented/fusion New Back Mixed A U A I
Instrumented/fusion New Back Nociceptive A A U I
Instrumented/fusion New Mixed Neuropathic A U A I
Instrumented/fusion New Mixed Mixed A U A I
Instrumented/fusion New Mixed Nociceptive A U U I
CON = conservative treatment
MIN = minimally invasive treatment A Appropriate
NEU = neurostimulation U Uncertain
ROP = re-operation I Inappropriate
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Table 6  Appropriateness of treatments for patients with anatomic evidence of spinal/foraminal stenosis
Treatment
Previous
Surgery
Onset
of pain
Location
of pain
Type
of pain CON MIN NEU ROP
Non-instrumented Remaining Leg Neuropathic U A U A
Non-instrumented Remaining Back Neuropathic U U U U
Non-instrumented Remaining Back Mixed A A U U
Non-instrumented Remaining Back Nociceptive U U I A
Non-instrumented Remaining Mixed Neuropathic U U U A
Non-instrumented Remaining Mixed Mixed U U U A
Non-instrumented Remaining Mixed Nociceptive U U U A
Non-instrumented Recurrent Leg Neuropathic U A A A
Non-instrumented Recurrent Back Neuropathic U U U U
Non-instrumented Recurrent Back Mixed U U U A
Non-instrumented Recurrent Back Nociceptive U U I A
Non-instrumented Recurrent Mixed Neuropathic A A A A
Non-instrumented Recurrent Mixed Mixed A A A A
Non-instrumented Recurrent Mixed Nociceptive A A U A
Non-instrumented New Leg Neuropathic A A U A
Non-instrumented New Back Neuropathic A A U U
Non-instrumented New Back Mixed A A U U
Non-instrumented New Back Nociceptive A U I A
Non-instrumented New Mixed Neuropathic U A A U
Non-instrumented New Mixed Mixed U A U A
Non-instrumented New Mixed Nociceptive U A U A
Instrumented/fusion Remaining Leg Neuropathic U U A A
Instrumented/fusion Remaining Back Neuropathic U U U U
Instrumented/fusion Remaining Back Mixed A U U U
Instrumented/fusion Remaining Back Nociceptive A U I U
Instrumented/fusion Remaining Mixed Neuropathic U U A A
Instrumented/fusion Remaining Mixed Mixed U U A A
Instrumented/fusion Remaining Mixed Nociceptive U U U A
Instrumented/fusion Recurrent Leg Neuropathic U U A A
Instrumented/fusion Recurrent Back Neuropathic A U U U
Instrumented/fusion Recurrent Back Mixed A U U U
Instrumented/fusion Recurrent Back Nociceptive A U I U
Instrumented/fusion Recurrent Mixed Neuropathic U U A A
Instrumented/fusion Recurrent Mixed Mixed U U U A
Instrumented/fusion Recurrent Mixed Nociceptive U U U A
Instrumented/fusion New Leg Neuropathic A U A U
Instrumented/fusion New Back Neuropathic A U U U
Instrumented/fusion New Back Mixed A U U U
Instrumented/fusion New Back Nociceptive A U I U
Instrumented/fusion New Mixed Neuropathic A U A U
Instrumented/fusion New Mixed Mixed A A U A
Instrumented/fusion New Mixed Nociceptive A U U A
CON = conservative treatment
MIN = minimally invasive treatment A Appropriate
NEU = neurostimulation U Uncertain
ROP = re-operation I Inappropriate
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Table 7  Appropriateness of treatments for patients with anatomic evidence of spinal instability
Treatment
Previous
Surgery
Onset
of pain
Location
of pain
Type
of pain CON MIN NEU ROP
Non-instrumented Remaining Leg Neuropathic U U I A
Non-instrumented Remaining Back Neuropathic U U I A
Non-instrumented Remaining Back Mixed U U I A
Non-instrumented Remaining Back Nociceptive U U I A
Non-instrumented Remaining Mixed Neuropathic U U U A
Non-instrumented Remaining Mixed Mixed U U U A
Non-instrumented Remaining Mixed Nociceptive U U I A
Non-instrumented Recurrent Leg Neuropathic U U U A
Non-instrumented Recurrent Back Neuropathic U U U A
Non-instrumented Recurrent Back Mixed A U U A
Non-instrumented Recurrent Back Nociceptive A U U A
Non-instrumented Recurrent Mixed Neuropathic U U U A
Non-instrumented Recurrent Mixed Mixed U U U A
Non-instrumented Recurrent Mixed Nociceptive U U U A
Non-instrumented New Leg Neuropathic A U U A
Non-instrumented New Back Neuropathic A U U A
Non-instrumented New Back Mixed A U U A
Non-instrumented New Back Nociceptive A U I A
Non-instrumented New Mixed Neuropathic A U U A
Non-instrumented New Mixed Mixed A U U A
Non-instrumented New Mixed Nociceptive A U U A
Instrumented/fusion Remaining Leg Neuropathic U U U A
Instrumented/fusion Remaining Back Neuropathic U U U A
Instrumented/fusion Remaining Back Mixed U U U A
Instrumented/fusion Remaining Back Nociceptive U U I A
Instrumented/fusion Remaining Mixed Neuropathic U U U A
Instrumented/fusion Remaining Mixed Mixed U U U A
Instrumented/fusion Remaining Mixed Nociceptive U U U A
Instrumented/fusion Recurrent Leg Neuropathic U U U A
Instrumented/fusion Recurrent Back Neuropathic U U U A
Instrumented/fusion Recurrent Back Mixed U U U A
Instrumented/fusion Recurrent Back Nociceptive U U I A
Instrumented/fusion Recurrent Mixed Neuropathic U U U A
Instrumented/fusion Recurrent Mixed Mixed U U U A
Instrumented/fusion Recurrent Mixed Nociceptive U U U A
Instrumented/fusion New Leg Neuropathic U U A A
Instrumented/fusion New Back Neuropathic A U U U
Instrumented/fusion New Back Mixed A U U A
Instrumented/fusion New Back Nociceptive A U I A
Instrumented/fusion New Mixed Neuropathic U U U U
Instrumented/fusion New Mixed Mixed U U U A
Instrumented/fusion New Mixed Nociceptive U U I A
CON = conservative treatment
MIN = minimally invasive treatment A Appropriate
NEU = neurostimulation U Uncertain
ROP = re-operation I Inappropriate
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